Seaport Therapeutics to Participate in September Investor Conferences
Seaport Therapeutics announced that members of its management team will participate in a series of investor conferences in September 2026, including one-on-one investor meetings. Co-Founder and CEO Daphne Zohar will deliver a company presentation and join a panel discussion at the Goldman Sachs Life Sciences Symposium on September 15, with additional appearances scheduled at H.C. Wainwright, Deutsche Bank, and TD Cowen events, including a fireside chat on September 23. Live webcasts and archived replays of the presentations will be available on the company's investor relations website.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.